DXCM vs NEPH · P/E 63, rev $2.50B vs P/E 48, rev $11.2M
DexCom Inc (DXCM) versus Nephros Inc (NEPH) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Nephros Inc (NEPH) is a medical instruments & supplies company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported NEPH revenue for 2026-06-30 was $11.2M. Net income was $1.3M. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
Not investment advice. Open the DXCM and NEPH stock pages for the full models.
Not investment advice.